University of Montpellier Researcher Publishes New Study Findings on Phosphotransferases (Alcohol Group Acceptor) (Targeting Protein Kinases to Protect Beta-Cell Function and Survival in Diabetes).

A new study conducted by researchers at the University of Montpellier in France explores the potential of targeting protein kinases to protect beta-cell function and survival in diabetes. The study highlights the increasing prevalence of diabetes worldwide and the need for effective treatments. While several drugs that inhibit protein kinases have been approved for cancer treatment, the development of safe drugs to protect beta-cells in diabetes remains unresolved. The study presents arguments suggesting that protein kinases in beta-cells could be potential targets for drug development in diabetes treatment. [Extracted from the article]

Copyright of Diabetes Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)